News & Updates
Filter by Specialty:

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
24 Oct 2024
byStephen Padilla
Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
24 Oct 2024
Statins counter heart risks in breast cancer radiotherapy
23 Oct 2024
byJairia Dela Cruz
For patients with breast cancer undergoing adjuvant radiotherapy, statin therapy appears to confer cardioprotective effects, mitigating the risk of major adverse cardiovascular event, according to a retrospective study.